The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.
about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSThe Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's diseaseLight and electron microscopy study of glycogen synthase kinase-3beta in the mouse brainGSK3beta: role in therapeutic landscape and development of modulators.Modelling the role of the Hsp70/Hsp90 system in the maintenance of protein homeostasis.Glycogen synthase kinase 3β (GSK3β) modulates antiviral activity of zinc-finger antiviral protein (ZAP).Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity.Altered regulation of tau phosphorylation in a mouse model of down syndrome agingAngiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?E-pharmacophore-based virtual screening to identify GSK-3β inhibitors.Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease ModelsPET radiopharmaceuticals for probing enzymes in the brainRole of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approachesNovel Non-phosphorylated Serine 9/21 GSK3β/α Antibodies: Expanding the Tools for Studying GSK3 RegulationVitamin B12 deficiency reduces proliferation and promotes differentiation of neuroblastoma cells and up-regulates PP2A, proNGF, and TACE.Amyloid precursor protein processing and Alzheimer's diseaseHow does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?Intranasal therapeutic strategies for management of Alzheimer's disease.MicroRNAs in glaucoma and neurodegenerative diseases.Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases.Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways.Binding of BIS like and other ligands with the GSK-3β kinase: a combined docking and MM-PBSA study.Discovery of Novel GSK-3β Inhibitors Using Pharmacophore and Virtual Screening Studies.GSK-3 and lysosomes meet in Alzheimer's disease.Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease.The Effects of Inhaled Pimpinella peregrina Essential Oil on Scopolamine-Induced Memory Impairment, Anxiety, and Depression in Laboratory Rats.Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance.Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.The peripheral messenger RNA expression of glycogen synthase kinase-3β genes in Alzheimer's disease patients: a preliminary study.
P2860
Q21129334-96E38C2C-B316-4442-9F49-8A0D068ED1C7Q28283403-85623E3F-C0C2-44E7-8155-BF2149AF61F9Q28472669-E095CA83-7C28-42A8-8E3C-B7076831D021Q33812730-35386353-F466-4B13-9E6C-A04646FA00ECQ33968220-24F90013-517E-44BE-A362-7090244F3625Q34238255-9822446D-288E-45E8-BDDD-F550660F6A07Q35070396-D4D3BF10-E3EC-4E81-AE78-F1AEC4ACEBAAQ35859514-3BE6092E-4E3D-45E6-9A07-33C7F08F21B5Q35971305-8DE0CCD6-CA63-4778-9408-4FB1C8BE6CCCQ36053324-9EB7B8DC-14F3-4653-AD9E-73C36FB0BEBDQ36128825-63E5CD58-B909-4C20-A108-99B06D22A5B7Q36769219-45DF9C98-84A8-45BB-BE49-575DA0E4C761Q36830938-BB13E00D-C231-416A-84EB-5302CE4AA725Q37418678-28A1B8A5-0BC6-4025-B050-5DCD79B1B59CQ37458465-885614EB-59A0-4760-A4EA-A9C4168B3EFCQ37860317-C986FA6A-0CDB-4952-BC2A-EAD3216CD9D3Q38069825-A3958E54-DC23-4C5F-AD17-4CC9D936C6CAQ38176935-9BE79831-75BB-4D82-B0CB-8D5307B63CA0Q38895922-AD886884-74CE-432A-92A9-4C998F853386Q39243689-89AE0AC3-3503-4292-8B89-48B2A8CB594BQ39316774-DC9EB7F5-060C-4332-937B-67081BD3EF9BQ39751752-1378EE37-EDD5-4E11-ADED-F83079093D19Q40616344-587251E5-5C16-4AC4-B0BD-F35E92C865DCQ42545605-321A55D4-D1BE-4A42-8512-AF23265B3877Q43516778-590688DE-A608-4A32-BF25-8E38C9D8B92DQ48037761-EDD9AC17-E4CE-48CF-BF36-A803A0B4E1EEQ48311391-54A7810D-3744-4FBD-A523-302E33C2CF76Q50707979-F82A1D4D-414D-4377-BEAD-15B053F07939Q50729633-29222749-C970-4511-8F1E-0FD5D4CA0812
P2860
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.
@en
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.
@nl
type
label
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.
@en
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.
@nl
prefLabel
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.
@en
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease.
@nl
P2860
P1433
P1476
The role of glycogen synthase kinase 3 in the early stages of Alzheimers' disease
@en
P2093
Jesús Avila
P2860
P304
P356
10.1016/J.FEBSLET.2008.10.026
P407
P50
P577
2008-10-26T00:00:00Z